These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33370317)

  • 41. Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.
    Mehta RS; Chong DQ; Song M; Meyerhardt JA; Ng K; Nishihara R; Qian Z; Morikawa T; Wu K; Giovannucci EL; Fuchs CS; Ogino S; Chan AT
    Gastroenterology; 2015 Sep; 149(3):614-22. PubMed ID: 26026393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the
    Chevolet I; Speeckaert R; Schreuer M; Neyns B; Krysko O; Bachert C; Hennart B; Allorge D; van Geel N; Van Gele M; Brochez L
    Oncoimmunology; 2015 Mar; 4(3):e982382. PubMed ID: 25949897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps.
    Johdi NA; Mazlan L; Sagap I; Jamal R
    Cytokine; 2017 Nov; 99():35-42. PubMed ID: 28689023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel method for screening colorectal cancer by infrared spectroscopy of peripheral blood mononuclear cells and plasma.
    Barlev E; Zelig U; Bar O; Segev C; Mordechai S; Kapelushnik J; Nathan I; Flomen F; Kashtan H; Dickman R; Madhala-Givon O; Wasserberg N
    J Gastroenterol; 2016 Mar; 51(3):214-21. PubMed ID: 26112122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of Colorectal Cancer Cell Proliferation by Regulating Platelet-Derived Growth Factor B Signaling with a DNA Aptamer.
    Sae-Lim S; Soontornworajit B; Rotkrua P
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):487-494. PubMed ID: 30803211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of PDGF-AB and sP-selectin concentrations in relation to platelet count in patients with colorectal cancer before and after surgical treatment.
    Mantur M; Koper O; Snarska J; Sidorska A; Kruszewska-Wnorowska K
    Pol Arch Med Wewn; 2008 Jun; 118(6):345-50. PubMed ID: 18619189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
    Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
    Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer.
    Lindmark G; Sundberg C; Glimelius B; Påhlman L; Rubin K; Gerdin B
    Lab Invest; 1993 Dec; 69(6):682-9. PubMed ID: 8264231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.
    Idorn M; Køllgaard T; Kongsted P; Sengeløv L; Thor Straten P
    Cancer Immunol Immunother; 2014 Nov; 63(11):1177-87. PubMed ID: 25085000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.
    OuYang LY; Wu XJ; Ye SB; Zhang RX; Li ZL; Liao W; Pan ZZ; Zheng LM; Zhang XS; Wang Z; Li Q; Ma G; Li J
    J Transl Med; 2015 Feb; 13():47. PubMed ID: 25638150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma.
    Pang X; Fan HY; Tang YL; Wang SS; Cao MX; Wang HF; Dai LL; Wang K; Yu XH; Wu JB; Tang YJ; Liang XH
    PLoS One; 2020; 15(2):e0229089. PubMed ID: 32092078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
    Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
    J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation.
    Ezzelarab MB; Perez-Gutierrez A; Humar A; Wijkstrom M; Zahorchak AF; Lu-Casto L; Wang YC; Wiseman RW; Minervini M; Thomson AW
    Transpl Immunol; 2019 Oct; 56():101225. PubMed ID: 31330261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetics of human myeloid-derived suppressor cells after blood draw.
    Grützner E; Stirner R; Arenz L; Athanasoulia AP; Schrödl K; Berking C; Bogner JR; Draenert R
    J Transl Med; 2016 Jan; 14():2. PubMed ID: 26733325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer.
    Olsen RS; Nijm J; Andersson RE; Dimberg J; Wågsäter D
    World J Gastroenterol; 2017 Sep; 23(34):6212-6219. PubMed ID: 28974887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant up-regulation of iNOS/NO system is correlated with an increased abundance of Foxp3
    Benkhelifa S; Rafa H; Belhadef S; Ait-Kaci H; Medjeber O; Belkhelfa M; Hetit S; Ait-Younes S; De Launoit Y; Moralès O; Mahfouf H; Delhem N; Touil-Boukoffa C
    Inflammopharmacology; 2019 Aug; 27(4):685-700. PubMed ID: 30680650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients.
    Elwan N; Salem ML; Kobtan A; El-Kalla F; Mansour L; Yousef M; Al-Sabbagh A; Zidan AA; Abd-Elsalam S
    Immunol Invest; 2018 Feb; 47(2):169-180. PubMed ID: 29182438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs.
    Porta C; Consonni FM; Morlacchi S; Sangaletti S; Bleve A; Totaro MG; Larghi P; Rimoldi M; Tripodo C; Strauss L; Banfi S; Storto M; Pressiani T; Rimassa L; Tartari S; Ippolito A; Doni A; Soldà G; Duga S; Piccolo V; Ostuni R; Natoli G; Bronte V; Balzac F; Turco E; Hirsch E; Colombo MP; Sica A
    Cancer Res; 2020 Jul; 80(13):2874-2888. PubMed ID: 32265223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.